162 related articles for article (PubMed ID: 31842422)
1. Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients.
Wang Q; Schmoeckel E; Kost BP; Kuhn C; Vattai A; Vilsmaier T; Mahner S; Mayr D; Jeschke U; Heidegger HH
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31842422
[TBL] [Abstract][Full Text] [Related]
2. Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia.
Vattai A; Kremer N; Meister S; Beyer S; Keilmann L; Buschmann C; Corradini S; Schmoeckel E; Kessler M; Mahner S; Jeschke U; Hertlein L; Kolben T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6613-6623. PubMed ID: 36792811
[TBL] [Abstract][Full Text] [Related]
3. FOXP3+ Cells Recruited by CCL22 into Breast Cancer Correlates with Less Tumor Nodal Infiltration.
Freier CP; Kuhn C; Endres S; Mayr D; Friese K; Jeschke U; Anz D
Anticancer Res; 2016 Jun; 36(6):3139-45. PubMed ID: 27272839
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Expressions of Immune Factors Facilitate the Disequilibrium of Immune Status in Cervical Cancer.
Zhao MY; Zhao J; Yang T; Wang L; Pei ML; Tian SJ; Yu Y; Yang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):522-527. PubMed ID: 27825407
[TBL] [Abstract][Full Text] [Related]
5. CCL1 is a major regulatory T cell attracting factor in human breast cancer.
Kuehnemuth B; Piseddu I; Wiedemann GM; Lauseker M; Kuhn C; Hofmann S; Schmoeckel E; Endres S; Mayr D; Jeschke U; Anz D
BMC Cancer; 2018 Dec; 18(1):1278. PubMed ID: 30572845
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating lymphocytes contain a higher proportion of FOXP3(+) T lymphocytes in cervical cancer.
Wu MY; Kuo TY; Ho HN
J Formos Med Assoc; 2011 Sep; 110(9):580-6. PubMed ID: 21930068
[TBL] [Abstract][Full Text] [Related]
7. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
8. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
[TBL] [Abstract][Full Text] [Related]
9. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H
Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer.
Kinoshita T; Muramatsu R; Fujita T; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Kudo-Saito C; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H; Kawakami Y
Ann Oncol; 2016 Nov; 27(11):2117-2123. PubMed ID: 27502728
[TBL] [Abstract][Full Text] [Related]
11. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
[TBL] [Abstract][Full Text] [Related]
12. Macrophage CCL22 expression in the tumor microenvironment and implications for survival in patients with squamous cell carcinoma of the tongue.
Kimura S; Nanbu U; Noguchi H; Harada Y; Kumamoto K; Sasaguri Y; Nakayama T
J Oral Pathol Med; 2019 Sep; 48(8):677-685. PubMed ID: 31134686
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients.
Wertel I; Surówka J; Polak G; Barczyński B; Bednarek W; Jakubowicz-Gil J; Bojarska-Junak A; Kotarski J
Tumour Biol; 2015 Jun; 36(6):4811-7. PubMed ID: 25647263
[TBL] [Abstract][Full Text] [Related]
14. C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy.
Wei Y; Wang T; Song H; Tian L; Lyu G; Zhao L; Xue Y
J Surg Res; 2017 May; 211():266-278. PubMed ID: 28501127
[TBL] [Abstract][Full Text] [Related]
15. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes.
Xia M; Zhao MQ; Wu K; Lin XY; Liu Y; Qin YJ
J Int Med Res; 2013 Aug; 41(4):1002-8. PubMed ID: 23760912
[TBL] [Abstract][Full Text] [Related]
16. Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate.
Wiedemann GM; Röhrle N; Makeschin MC; Fesseler J; Endres S; Mayr D; Anz D
Pathology; 2019 Oct; 51(6):586-592. PubMed ID: 31445808
[TBL] [Abstract][Full Text] [Related]
17. Negative immune factors might predominate local tumor immune status and promote carcinogenesis in cervical carcinoma.
Zhao M; Li Y; Wei X; Zhang Q; Jia H; Quan S; Cao D; Wang L; Yang T; Zhao J; Pei M; Tian S; Yu Y; Guo Y; Yang X
Virol J; 2017 Jan; 14(1):5. PubMed ID: 28086903
[TBL] [Abstract][Full Text] [Related]
18. Tumour-infiltrating FoxP3+ and IL-17-producing T cells affect the progression and prognosis of gallbladder carcinoma after surgery.
Zhang Y; Huang Y; Qin M
Scand J Immunol; 2013 Dec; 78(6):516-22. PubMed ID: 24007242
[TBL] [Abstract][Full Text] [Related]
19. The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients.
Heidegger H; Dietlmeier S; Ye Y; Kuhn C; Vattai A; Aberl C; Jeschke U; Mahner S; Kost B
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753926
[TBL] [Abstract][Full Text] [Related]
20. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L
Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
